Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Trovagene Inc

+ Add to Watchlist

TROV:US

6.8100 USD 0.1900 2.71%

As of 20:10:00 ET on 03/31/2015.

Snapshot for Trovagene Inc (TROV)

Open: 7.0000 Day's Range: 6.7300 - 7.0600 Volume: 114,246
Previous Close: 7.0000 52wk Range: 2.9700 - 8.0400 1-Yr Rtn: +18.85%

Stock Chart for TROV

No chart data available.
  • TROV:US 6.8100
  • 1D
  • 1M
  • 1Y
7.0000
Interactive TROV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TROV

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8492
Est. EPS (USD) (12/2015) -0.8950
Est. PEG Ratio -
Market Cap (M USD) 164.28
Shares Outstanding (M) 24.12
30 Day Average Volume 259,174
Price/Book (mrq) 16.6353
Price/Sale (ttm) 460.1101
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TROV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TROV

Trovagene, Inc. is an applied genomics company. The Company is developing a non-invasive testing technology using transrenal nucleic acid (TrNA) markers for infectious diseases, prenatal testing, early detection of cancer, and monitoring of organ and cell transplantation.

Antonius P Schuh "Tony"Chief Executive OfficerStephen L Zaniboni "Steve"Chief Financial Officer
Mark ErlanderChief Scientific OfficerMatthew L Posard "Matt"Exec VP/Chief Commercial Ofcr
More Company Profile & Key Executives for TROV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil